chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Haemorrhage urinary tract, Magnetic resonance imaging, Musculoskeletal stiffness, Nausea, Renal cancer
Clinical narrative: I'm unsure about the exact connection to the vaccination event, since shortly after I experienced only mild and symptoms. Following weeks and month however I felt more fatigued than usual, more sluggishness until at the end of December and January. Stiffness,  nausea , some issue with hearing, nothing appeared overly significant. In January my blood pressure increased  and never went down - not even beta blocker medication helped it.  As of April however severe bleeding started through the urinary tract and I'm told that I'm having advanced renal carcinoma. A few month prior, 06/18/22 there was no sign of anything on sonogram, no lab test show any indication of such disease. Now, one of my kidney and more is essentially gone as it is engulfed by supposedly cancerous growth and infiltrations. . Nothing other than vaccination took place during those few month, the bivalent Pfizer  and flu shot about a month later. I have never had a positive covid test and I live mindfully about the risk. Exams, imaging and high risk surgery is suggested. Is there knowledge of such unwanted effect however rare it might be?
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Renal disorder, Sluggishness, Ultrasound scan normal
Clinical narrative: I'm unsure about the exact connection to the vaccination event, since shortly after I experienced only mild and symptoms. Following weeks and month however I felt more fatigued than usual, more sluggishness until at the end of December and January. Stiffness,  nausea , some issue with hearing, nothing appeared overly significant. In January my blood pressure increased  and never went down - not even beta blocker medication helped it.  As of April however severe bleeding started through the urinary tract and I'm told that I'm having advanced renal carcinoma. A few month prior, 06/18/22 there was no sign of anything on sonogram, no lab test show any indication of such disease. Now, one of my kidney and more is essentially gone as it is engulfed by supposedly cancerous growth and infiltrations. . Nothing other than vaccination took place during those few month, the bivalent Pfizer  and flu shot about a month later. I have never had a positive covid test and I live mindfully about the risk. Exams, imaging and high risk surgery is suggested. Is there knowledge of such unwanted effect however rare it might be?
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Child presented with erythema, swelling and warmth on L arm. Seen by Pediatrician and given Cephalexin 500 mg three times a day orally.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 02/25/23 presents to ED for "breathing problem". PMHx of "diabetes, hypertension, hyperlipidemia, morbid obesity, paroxysmal atrial fibrillation on Eliquis, chronic respiratory failure"
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 02/27/23 presents to ED for "shortness of breath". PMHx of "HIV, type 2 diabetes"
Age: 14.0
Sex: M
Vaccine: HPV9, HPV9
Symptoms: Asthma, Chest X-ray, Condition aggravated
Clinical narrative: asthma exacerbation / wheezing; the night of 4/24/2023, his soon began "having a lot of trouble"; on 4/23/2023 his son began complaining about discomfort; This spontaneous report has been received from the patient's father concerning a 14-year-old male patient. His concurrent conditions included a mild case of asthma, medical history, drug reactions/allergies, and concomitant medications were not provided.   On 18-APR-2023, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) administered as prophylaxis (dosage regimen, route of administration, lot number and expiration date were not provided).   On 23-APR-2023, the patient began complaining about discomfort (Discomfort). On 24-APR-2023, the patient began "having a lot of trouble" (Ill-defined disorder) and was wheezing. On 25-APR-2023, the patient was sent to the local emergency room where he was treated, but then discharged, treatments received were not specified. On the same date (also reported as "that same evening"), the patient's wheezing began worsening and the patient's father took him to a different emergency room on 26-APR-2023 and the patient was admitted to the hospital for an asthma exacerbation (Asthma), the patient had not experienced asthma exacerbation before receiving HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). While in the hospital the patient was treated with albuterol nebulizer treatments, oral steroids (dexamethasone) and magnesium intravenously (IV). On 28-APR-2023, the patient was discharged. The patient continued to have some wheezing in his right lung and was sent home with an albuterol inhaler and an "inhaled steroid". Outcome of the events was reported ad resolving.   Causal relationship between HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) and the events was not reported.
Age: 14.0
Sex: M
Vaccine: HPV9, HPV9
Symptoms: Asthma, Condition aggravated, Discomfort, Ill-defined disorder, Wheezing
Clinical narrative: asthma exacerbation / wheezing; the night of 4/24/2023, his soon began "having a lot of trouble"; on 4/23/2023 his son began complaining about discomfort; This spontaneous report has been received from the patient's father concerning a 14-year-old male patient. His concurrent conditions included a mild case of asthma, medical history, drug reactions/allergies, and concomitant medications were not provided.   On 18-APR-2023, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) administered as prophylaxis (dosage regimen, route of administration, lot number and expiration date were not provided).   On 23-APR-2023, the patient began complaining about discomfort (Discomfort). On 24-APR-2023, the patient began "having a lot of trouble" (Ill-defined disorder) and was wheezing. On 25-APR-2023, the patient was sent to the local emergency room where he was treated, but then discharged, treatments received were not specified. On the same date (also reported as "that same evening"), the patient's wheezing began worsening and the patient's father took him to a different emergency room on 26-APR-2023 and the patient was admitted to the hospital for an asthma exacerbation (Asthma), the patient had not experienced asthma exacerbation before receiving HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). While in the hospital the patient was treated with albuterol nebulizer treatments, oral steroids (dexamethasone) and magnesium intravenously (IV). On 28-APR-2023, the patient was discharged. The patient continued to have some wheezing in his right lung and was sent home with an albuterol inhaler and an "inhaled steroid". Outcome of the events was reported ad resolving.   Causal relationship between HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) and the events was not reported.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Moderna 3/2/21 Lot# 025A21A; MOderna 3/30/21 Lot# 016B21A;  Moderna 12/6/21 Lot# 045F21A;
Sex: U
Vaccine: MMRV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AEs; Caller reported expired dose of PROQUAD was administered.  No other information provided.  No additional AEs or PQC reported.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender.  Information regarding the patient's medical history, concurrent conditions, and past drug allergies or drug reactions were not provided. Concomitant medication included sterile diluent (0.7 milliliter (mL), lot # W025272, expiration date reported and stablished as 04-OCT-2023).  On 19-APR-2023, the patient was vaccinated with an expire dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) subcutaneous injection 0.5 mL, subcutaneously (lot #U031563 confirmed to be a valid lot number with an expiration date reported and stablished as 06-APR-2023) administered as prophylaxis (strength and anatomical location were not provided) (expired product administered). No additional adverse event (AE's) was reported (no adverse event).
Sex: U
Vaccine: MMR, VARCEL
Symptoms: Expired product administered
Clinical narrative: Confirmed no other AE occurred; An expired dose of MMRIII was administered; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender.  The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 19-APR-2023, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (lot number w005208 has been determined to be valid for varicella virus vaccine live (oka/merck) (VARIVAX), expiration date reported and established as 14-FEB-2024), and on 20-APR-2023, the patient was vaccinated with the first dose of an expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (expired product administered) subcutaneous injection (lot number u007686 has been determined to be valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), expiration date reported and established as 09-MAR-2023), both administered for prophylaxis (strength,  dose, frequency and anatomical site of administration were not provided).
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AEs; Vaccine was administered after temperature excursion; This spontaneous report was received from a office manager referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies/reactions or concomitant medications was not provided.  On 18-APR-2023, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA SYRINGE (DEVICE)), for prophylaxis (lot #W036135; expiration date: 13-MAY-2024) (dosage, vaccination scheme, frequency, route of administration, anatomical site of injection were not reported). The administered dose of the vaccine was stored at a temperature of 34.75 degrees Fahrenheit (F), for a time frame of 15 minutes, as recorded by a digital data logger. There was a previous temperature excursion of 35.2 Fahrenheit (F) for 30 minutes; 35.2 Fahrenheit (F) for 30 minutes. There was no adverse effect reported.
Sex: U
Vaccine: VARZOS
Symptoms: Mobility decreased, Pain
Clinical narrative: The vaccine hurts; couldn't lift arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: The vaccine hurts) and mobility decreased (Verbatim: couldn't lift arm). The outcome of the pain and mobility decreased were not reported.   It was unknown if the reporter considered the pain and mobility decreased to be related to Shingles vaccine.     It was unknown if the company considered the pain and mobility decreased to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 30-APR-2023 This case was reported by the patient via interactive digital media. The patient received a dose of Shingles vaccine and reported that the vaccine hurt, and his/her arm felt he/she could not lift it. The patient reported that, okay but the disease was worse and reported that the vaccine protected them and stated that they have to get the second as well.  Follow-up would not possible, as no contact details were available.
Age: 38.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; 01May2023, for their 2nd dose of the Covid-19 vaccine.previous dose was Pfizer but since they do not have Pfizer available,they gave the Moderna bivalent vaccine.1st dose was administered on 05Apr2023 bivalent; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (01May2023, for their 2nd dose of the Covid-19 vaccine.previous dose was Pfizer but since they do not have Pfizer available,they gave the Moderna bivalent vaccine.1st dose was administered on 05Apr2023 bivalent) and NO ADVERSE EVENT (No adverse event) in a 38-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1) on 05-Apr-2023. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE.    On 01-May-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 01-May-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (01May2023, for their 2nd dose of the Covid-19 vaccine.previous dose was Pfizer but since they do not have Pfizer available,they gave the Moderna bivalent vaccine.1st dose was administered on 05Apr2023 bivalent). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (01May2023, for their 2nd dose of the Covid-19 vaccine.previous dose was Pfizer but since they do not have Pfizer available,they gave the Moderna bivalent vaccine.1st dose was administered on 05Apr2023 bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (01May2023, for their 2nd dose of the Covid-19 vaccine.previous dose was Pfizer but since they do not have Pfizer available,they gave the Moderna bivalent vaccine.1st dose was administered on 05Apr2023 bivalent).    No concomitant medications was provided. No treatment medications was provided. Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; a patient received a dose of an expired Moderna COVID-19 monovalent vaccine from a vial that expired on 11MAR2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (a patient received a dose of an expired Moderna COVID-19 monovalent vaccine from a vial that expired on 11MAR2023) and NO ADVERSE EVENT (No adverse event) in a 22-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 074B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-May-2023, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-May-2023,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (a patient received a dose of an expired Moderna COVID-19 monovalent vaccine from a vial that expired on 11MAR2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (a patient received a dose of an expired Moderna COVID-19 monovalent vaccine from a vial that expired on 11MAR2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (a patient received a dose of an expired Moderna COVID-19 monovalent vaccine from a vial that expired on 11MAR2023).    No concomitant medications was provided. No treatment medications was provided. The patient received the expired dose of the vaccine on, 2MAY2023 and had not reported any adverse reactions Vial size was Unknown Vial did not undergo any temperature excursion. Individual vial was reported in source document.
Age: 62.0
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Post herpetic neuralgia
Clinical narrative: post herpetic neuralgia; multiple outbreaks of herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently approximately 78-year-old patient (pt) of unknown gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 28-FEB-2007, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose and route were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date (reported as subsequently), the pt was treated by providers for the following injuries resulting from pt's zoster vaccine live (ZOSTAVAX) use: multiple outbreaks of herpes zoster and post herpetic neuralgia. The outcome of the events was not reported. The lawyer considered the events to be related to zoster vaccine live (ZOSTAVAX).
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: rash at injection site; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number Xy22f, expiry date 27-MAY-2024) for prophylaxis.   On 04-FEB-2023, the patient received the 1st dose of Shingrix (unknown arm). On 04-FEB-2023, 2 hrs after receiving Shingrix, the patient experienced injection site rash (Verbatim: rash at injection site). The outcome of the injection site rash was resolved (duration 6 hrs).   It was unknown if the reporter considered the injection site rash to be related to Shingrix.     It was unknown if the company considered the injection site rash to be related to Shingrix.   Additional Information: GSK Receipt Date:3-May-2023  The pharmacist reported that a patient developed a rash at their Shingrix injection site about 2 hrs after getting their first vaccine.  The patient reported that the rash resolved about 6 hrs afterwards. The reporter consented to follow up.
Age: 39.0
Sex: M
Vaccine: HEPA, HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: No additional AEs or PQC reported; Caller states 1st dose was administered on 10/11/2022 and 2nd dose was administered on 1/18/2023.; This spontaneous report has been received from a medical assistant and refers to a 39-year-old male patient.  The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 11-OCT-2022, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 milliliter (ml). On 18-JAN-2023, being too early, the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 milliliter (inappropriate schedule of product administration) (lot number reported for both doses U036184 has been determined to be valid for hepatitis a vaccine, inactivated (VAQTA), expiration date reported and established as 02-MAR-2023), both administered intramuscularly for prophylaxis (strength was not provided).
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No Adverse Event; Temperature excursion   ?; This spontaneous report was received from an administrative refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 27-APR-2023, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot# W035464, expiration date: 06-MAY-2024 (exact dose, route of administration and anatomical location were not reported) for prophylaxis.  On 27-APR-2023, administered dose of vaccines was exposed to the temperature excursion of -10 degrees Celsius for 59 minutes (product storage error) No previous temperature excursion had occurred. There were no additional adverse events reported (no adverse event).
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Syringe issue
Clinical narrative: Error: Leaking from Syringe-
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium
Age: 27.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cerebrovascular accident
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Stroke-Severe, Additional Details: Patients husband came in to report patient had stroke about a week after getting covid booster and first shingrix shot and was hospitalized for a week
Age: 29.0
Sex: M
Vaccine: VARZOS
Symptoms: No adverse event, Product preparation error
Clinical narrative: Patient presented for routine followup.  Provider ordered shingrix vaccination.  Patient was only given the diluent portion of vaccination instead of mixing with powder prior to administration.  No adverse reactions noted.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Symptom recurrence
Clinical narrative: ALLERGIC REACTION, INIT 12/8/2021 -- RECURRENCE OF SAME SYMPTOMS
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: -Urticarial rash Pt received 2 Epinephrine .3 S/C dose + Benadryl 50 IM
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: I received a Johnson and Johnson covid vaccine from the fire Department and got covid requiring 2 months hospitalization and also had several blood clots in my right leg.i was put on zarelto and sent home from the hospital. 1 week ago I had to go back to the hospital for more blood clots in my right leg. After doing an ultrasound again the Dr reported to me that most of the same blood clots were still there and some had connected forming a rather large one there. I was diagnosed with chronic DVR right lower extremity and am being referred to a hemotologist and a vascular surgeon. I think it's related to the vaccine
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebellar artery occlusion, Cerebrovascular accident
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE DUE TO OCCLUSION OF RIGHT CEREBELLAR ARTERY
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE DVT OF LEFT FEMORAL VEIN ACUTE DVT OF LEFT POPLITEAL VEIN
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient given monovalent Moderna vaccine that was expired 3/11/2023 on 5/2/2023
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Lacunar stroke, Transient ischaemic attack
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  TRANSIENT CEREBRAL ISCHEMIA ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 3/20/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Heart rate abnormal, SARS-CoV-2 test positive, Thrombosis
Clinical narrative: 6/28/22  I started being very short of breath. A couple of days later, I tested for COVID with an at home test and tested positive. I went to the doctor and he did not prescribe anything and if it got worse, to go to the Emergency Room.  I did have an abnormal heart rate, short of breath and still have blood clots.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound scan abnormal
Clinical narrative: 6/28/22  I started being very short of breath. A couple of days later, I tested for COVID with an at home test and tested positive. I went to the doctor and he did not prescribe anything and if it got worse, to go to the Emergency Room.  I did have an abnormal heart rate, short of breath and still have blood clots.
Age: 5.0
Sex: M
Vaccine: HEP, HPV9, IPV
Symptoms: No adverse event
Clinical narrative: NO ADVERSE REACTIONS
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Hypotension
Clinical narrative: ACUTE NON ST ELEVATION MI ACUTE MI HYPOTENSION
Age: 41.0
Sex: M
Vaccine: UNK
Symptoms: Decreased appetite, Dyspnoea, Fatigue, Headache
Clinical narrative: CANT BREATH, LOSS OF APPETITE, ALWAYS TIRED, HEADACHE
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Nasopharyngitis, No adverse event
Clinical narrative: I did not have an adverse reaction to the vaccine. In 02/2023, I developed a cold with a cough. I contacted my doctor and got a prescription for cough medicine with codeine. In 04/2023, my seasonal allergies started to bother me.  The cough started up again and I used the cough medicine with codeine.
Age: 74.0
Sex: F
Vaccine: PNC20
Symptoms: Blood glucose normal, Coma, Dyspnoea, Feeling abnormal, Heart rate decreased
Clinical narrative: Patient had labs drawn and returned to room for Prevnar 20 and ear irrigation -as her irrigation was started, she began to feel bad, asked to lay down -she became unresponsive, had lateral nystagmus -her breathing pattern changed, gasping and slowed - EMS called -BG was taken: 130 -Pulse ox 91, HR 55 -she was unresponsive 1-2 minutes, then responsive to name -she was diaphoretic -she continued to be sedated but arousable to name -she started vomiting - HR down to 51 and pulse 88% -EMS arrived and patient to be taken to facility
Age: 74.0
Sex: F
Vaccine: PNC20
Symptoms: Hyperhidrosis, Nystagmus, Respiration abnormal, Unresponsive to stimuli
Clinical narrative: Patient had labs drawn and returned to room for Prevnar 20 and ear irrigation -as her irrigation was started, she began to feel bad, asked to lay down -she became unresponsive, had lateral nystagmus -her breathing pattern changed, gasping and slowed - EMS called -BG was taken: 130 -Pulse ox 91, HR 55 -she was unresponsive 1-2 minutes, then responsive to name -she was diaphoretic -she continued to be sedated but arousable to name -she started vomiting - HR down to 51 and pulse 88% -EMS arrived and patient to be taken to facility
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Amnesia, Arthralgia, Fatigue, Hypertension, Laboratory test
Clinical narrative: memory loss high blood pressure  Joint and muscle pain Fatigue
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: memory loss high blood pressure  Joint and muscle pain Fatigue
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anal incontinence, Body temperature decreased, Vomiting
Clinical narrative: the next morning I lost all control of my bowels and threw up.  My body temperature was down to 92.  I got into a hot bath immediately when I realized how dangerous it was and got my temperature back up to 97.  Blood pressure 93/61 and heart 50.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema
Clinical narrative: ANGIOEDEMA, INIT ANGIOEDEMA, SEQUELA
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute pulmonary oedema, Atrial fibrillation, Brain natriuretic peptide, COVID-19, Cardiac failure congestive
Clinical narrative: 92-year-old male with history of CHF presents emergency department by EMS from local residential facility.  He is complaining of difficulty breathing.  He was hypoxic at 86% on room air at the nursing home.  He arrived on a CPAP by basic EMS and is 96%.  He got an albuterol treatment in route.  He recently tested positive for COVID.  He denies chest pain.  No fever.  He is nontoxic in appearance.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Condition aggravated, Dyspnoea, Electrocardiogram abnormal, Hypoxia
Clinical narrative: 92-year-old male with history of CHF presents emergency department by EMS from local residential facility.  He is complaining of difficulty breathing.  He was hypoxic at 86% on room air at the nursing home.  He arrived on a CPAP by basic EMS and is 96%.  He got an albuterol treatment in route.  He recently tested positive for COVID.  He denies chest pain.  No fever.  He is nontoxic in appearance.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Lung infiltration, Positive airway pressure therapy, SARS-CoV-2 test positive, Troponin, White blood cell count
Clinical narrative: 92-year-old male with history of CHF presents emergency department by EMS from local residential facility.  He is complaining of difficulty breathing.  He was hypoxic at 86% on room air at the nursing home.  He arrived on a CPAP by basic EMS and is 96%.  He got an albuterol treatment in route.  He recently tested positive for COVID.  He denies chest pain.  No fever.  He is nontoxic in appearance.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPERCAPNIC RESPIRATORY FAILURE
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Pulmonary embolism, Respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA 6/10/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA 6/10/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: BUD date excursion, vaccine given after the BUD. BUD date was 4-7-23, and was administered 4-22-23.
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Exposure to SARS-CoV-2, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I had a really sore throat; my husband had tested positive for COVID-19 early so I thought I should test myself just in case I had gotten it. I took a home COVID-19 test that came back positive. I contacted my doctor through the portal, letting them know I had tested positive with a home COVID-19 test. They let me know I needed to go their testing site to get a PCR COVID-19. One the test came back positive, my doctor prescribed Paxlovid, I was able to start the medication on Friday.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial flutter, Hypotension
Clinical narrative: Pfizer vaccine was administered outside of our facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------- I95.9 HYPOTENSION 12/26/2021 UNSPECIFIED ATRIAL FLUTTER
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: HYPOXIA 10/25/2022 --  RECURRENCE OF SAME SYMPTOMS
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Fatigue, Myalgia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Symptoms began 05/02/2023, muscle aches, fever, UTI  and fatigue. Case tested positive 05/05/20223 at hospital. Was admitted 05/06/2023.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Urinary tract infection
Clinical narrative: Symptoms began 05/02/2023, muscle aches, fever, UTI  and fatigue. Case tested positive 05/05/20223 at hospital. Was admitted 05/06/2023.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Hypotension, Shock
Clinical narrative: I95.9 HYPOTENSION 3/9/2022 NONTRAUMATIC ACUTE KIDNEY INJURY J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/9/2022 NONTRAUMATIC ACUTE KIDNEY INJURY R57.9 SHOCK, UNSPECIFIED 3/9/2022 NONTRAUMATIC ACUTE KIDNEY INJURY
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE 6/25/2022 &  7/3/2022  --  RECURRENCE OF SAME SYMPTOMS
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Clostridium difficile infection, Condition aggravated, Pneumonia, Respiratory failure
Clinical narrative: Discharge Provider: MD Primary Care Provider:  MD Admission Date: 4/6/2023 Discharge Date: Apr 11, 2023  PRESENTING PROBLEM: Respiratory failure with hypoxia (HCC) Pneumonia of right lung due to infectious organism, unspecified part of lung   HOSPITAL COURSE: Patient is an 82-year-old woman with past medical history significant for stage II squamous cell carcinoma of the lung status post radiation therapy, severe aortic stenosis status post TAVR, chronic obstructive pulmonary disease, paroxysmal atrial fibrillation, and heart failure preserved ejection fraction who was admitted on 04/06 for acute hypoxic respiratory failure secondary to multifocal pneumonia. She was placed on 2L NC and started IV antibiotics with cefepime and azithromycin. She developed diarrhea on antibiotics and ID was consulted as she had recent history of indeterminate C. Diff infection with oral vancomycin treatment.  Her C difficile came back indeterminate, Infectious Disease recommended start the patient on oral vancomycin for a total duration of 10 days.  The patient completed her IV antibiotics for hospital-acquired pneumonia, we were not able to wean her oxygen requirements, pulmonary rehab was consulted and they evaluated the patient, she was requiring 2 L on ambulation and 1 L at rest.  Oxygen was arranged at discharge, and patient was discharged on 04/11 in a stable condition.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Pt experienced hair loss after 2nd dose of Pfizer Covid vaccine
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: BUD date excursion. BUD was 4-7-23 and vaccine was administered 4-22-23.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Brain fog, Condition aggravated, Fatigue, Headache
Clinical narrative: I started with a sore throat in March 30, 2023 which progressed into sinus infection, brain fog and headaches.  I really had bad allergies since my vaccine. My sinus congestion and hay fever got worse, and I was getting concerned. I called my doctor who gave me Doxycycline. I felt exhausted and could hardly function and I was feeling nauseous. I also vomited several times.  I went to my doctor office who examined me and he put me on Levaquin and it made me sick as well which I took for four days. It has taken me a bit to feel better within this past week but I still get a brain fog at times.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Loss of personal independence in daily activities, Nausea, Oropharyngeal pain, Sinus congestion
Clinical narrative: I started with a sore throat in March 30, 2023 which progressed into sinus infection, brain fog and headaches.  I really had bad allergies since my vaccine. My sinus congestion and hay fever got worse, and I was getting concerned. I called my doctor who gave me Doxycycline. I felt exhausted and could hardly function and I was feeling nauseous. I also vomited several times.  I went to my doctor office who examined me and he put me on Levaquin and it made me sick as well which I took for four days. It has taken me a bit to feel better within this past week but I still get a brain fog at times.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis, Vomiting
Clinical narrative: I started with a sore throat in March 30, 2023 which progressed into sinus infection, brain fog and headaches.  I really had bad allergies since my vaccine. My sinus congestion and hay fever got worse, and I was getting concerned. I called my doctor who gave me Doxycycline. I felt exhausted and could hardly function and I was feeling nauseous. I also vomited several times.  I went to my doctor office who examined me and he put me on Levaquin and it made me sick as well which I took for four days. It has taken me a bit to feel better within this past week but I still get a brain fog at times.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood culture negative, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Attending Physician: MD Date of Admission: 4/12/2023, Hospital Day: 4 Date of Discharge: 4/15/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Metabolic encephalopathy [G93.41] Respiratory insufficiency [R06.89] Sepsis due to pneumonia [J18.9, A41.9] Community acquired pneumonia, unspecified laterality [J18.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID-19 [U07.1]   HOSPITAL COURSE: 73yo woman with a PMH chronic right knee pain, allergic rhinitis, GERD, COPD and HTN here with acute encephalopathy for unclear reason. It looked infectious in etiology and workup was broad including workup of her acute on chronic right knee/leg pain. MRI right knee and xray of ankle were negative for infection but did show medial and lateral meniscus tears. Urinalysis was obtained and looks suspicious for UTI. Urine culture came back with klebsiella sensitive to the antibiotics that she is on for pneumonia. CXR was suggestive of pneumonia.and sepsis secondary covid 19 PNA with superimposed bacterial pneumonia. She had persistent high fevers with altered mentation which quickly resolved with antibiotic administration. Blood cultures remained NGTD at time of dictation. She was given decadron and remdesivir for covid which she tolerated well. She did have acute respiratory failure but was able to be weaned off oxygen and did not qualify for oxygen prior to discharge. She was transitioned to ceftin to complete her course of antibiotics. She was discharged to home in stable and improved condition with referral to the transition to home program.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Culture urine positive, Encephalopathy, Klebsiella test positive, Magnetic resonance imaging abnormal, Meniscus injury
Clinical narrative: Attending Physician: MD Date of Admission: 4/12/2023, Hospital Day: 4 Date of Discharge: 4/15/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Metabolic encephalopathy [G93.41] Respiratory insufficiency [R06.89] Sepsis due to pneumonia [J18.9, A41.9] Community acquired pneumonia, unspecified laterality [J18.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID-19 [U07.1]   HOSPITAL COURSE: 73yo woman with a PMH chronic right knee pain, allergic rhinitis, GERD, COPD and HTN here with acute encephalopathy for unclear reason. It looked infectious in etiology and workup was broad including workup of her acute on chronic right knee/leg pain. MRI right knee and xray of ankle were negative for infection but did show medial and lateral meniscus tears. Urinalysis was obtained and looks suspicious for UTI. Urine culture came back with klebsiella sensitive to the antibiotics that she is on for pneumonia. CXR was suggestive of pneumonia.and sepsis secondary covid 19 PNA with superimposed bacterial pneumonia. She had persistent high fevers with altered mentation which quickly resolved with antibiotic administration. Blood cultures remained NGTD at time of dictation. She was given decadron and remdesivir for covid which she tolerated well. She did have acute respiratory failure but was able to be weaned off oxygen and did not qualify for oxygen prior to discharge. She was transitioned to ceftin to complete her course of antibiotics. She was discharged to home in stable and improved condition with referral to the transition to home program.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Mental status changes, Metabolic encephalopathy, Pneumonia, Pneumonia bacterial, Pyrexia
Clinical narrative: Attending Physician: MD Date of Admission: 4/12/2023, Hospital Day: 4 Date of Discharge: 4/15/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Metabolic encephalopathy [G93.41] Respiratory insufficiency [R06.89] Sepsis due to pneumonia [J18.9, A41.9] Community acquired pneumonia, unspecified laterality [J18.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID-19 [U07.1]   HOSPITAL COURSE: 73yo woman with a PMH chronic right knee pain, allergic rhinitis, GERD, COPD and HTN here with acute encephalopathy for unclear reason. It looked infectious in etiology and workup was broad including workup of her acute on chronic right knee/leg pain. MRI right knee and xray of ankle were negative for infection but did show medial and lateral meniscus tears. Urinalysis was obtained and looks suspicious for UTI. Urine culture came back with klebsiella sensitive to the antibiotics that she is on for pneumonia. CXR was suggestive of pneumonia.and sepsis secondary covid 19 PNA with superimposed bacterial pneumonia. She had persistent high fevers with altered mentation which quickly resolved with antibiotic administration. Blood cultures remained NGTD at time of dictation. She was given decadron and remdesivir for covid which she tolerated well. She did have acute respiratory failure but was able to be weaned off oxygen and did not qualify for oxygen prior to discharge. She was transitioned to ceftin to complete her course of antibiotics. She was discharged to home in stable and improved condition with referral to the transition to home program.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure, Sepsis, Superinfection, Urine analysis abnormal, X-ray limb normal
Clinical narrative: Attending Physician: MD Date of Admission: 4/12/2023, Hospital Day: 4 Date of Discharge: 4/15/2023  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Metabolic encephalopathy [G93.41] Respiratory insufficiency [R06.89] Sepsis due to pneumonia [J18.9, A41.9] Community acquired pneumonia, unspecified laterality [J18.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present [A41.9] COVID-19 [U07.1]   HOSPITAL COURSE: 73yo woman with a PMH chronic right knee pain, allergic rhinitis, GERD, COPD and HTN here with acute encephalopathy for unclear reason. It looked infectious in etiology and workup was broad including workup of her acute on chronic right knee/leg pain. MRI right knee and xray of ankle were negative for infection but did show medial and lateral meniscus tears. Urinalysis was obtained and looks suspicious for UTI. Urine culture came back with klebsiella sensitive to the antibiotics that she is on for pneumonia. CXR was suggestive of pneumonia.and sepsis secondary covid 19 PNA with superimposed bacterial pneumonia. She had persistent high fevers with altered mentation which quickly resolved with antibiotic administration. Blood cultures remained NGTD at time of dictation. She was given decadron and remdesivir for covid which she tolerated well. She did have acute respiratory failure but was able to be weaned off oxygen and did not qualify for oxygen prior to discharge. She was transitioned to ceftin to complete her course of antibiotics. She was discharged to home in stable and improved condition with referral to the transition to home program.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site pain, Peripheral swelling, Pruritus, Sleep disorder
Clinical narrative: I experienced pain in my left arm at the injection site, my arm became red, swollen and itchy. My arm kept me awake for several nights, by the time I saw my PCP the itching had simmered down and my arm wasn't quite as red as it was before. My PCP suggested an over the counter antihistamine and the symptoms resolved in a week.
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: BUD date excursion. BUD was 4-7-23 and vaccine administered 4-22-23.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pain in extremity, Rash vesicular, Skin warm
Clinical narrative: vesicular rash and arm pain, warmth and redness
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Unevaluable event
Clinical narrative: Unknown. Unable to contact case due to hospitalization on 05/02/2023.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Angina pectoris, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE STABLE ANGINA ACUTE NON ST ELEVATION MI 2/7/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: BUD date excursion, BUD was 4-7-23 and vaccine administered. 4-22-23
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Gout, Hypotension
Clinical narrative: I95.9 HYPOTENSION 5/22/2022 GOUT
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Cough, Eosinophilic pneumonia, Lung opacity
Clinical narrative: I was coughing a lot; I went to my primary care physician who referred me to a pulmonary physician. My pulmonary physician took x-rays, she said my lungs looked like I had broken glass in my lungs. She diagnosed me with eosinophilic pneumonia, I was prescribed an inhaler to help me breath and prednisone. I get better, I get worse.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE 4/15/2022 -- RECURRENCE OF SAME SYMPTOMS
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism, Syncope
Clinical narrative: I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 4/8/2021 SYNCOPE I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 5/11/2021 SYNCOPE
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: BUD date excursion, BUD was 4-7-23 and vaccine administered. 4-21-23.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood test, Computerised tomogram abdomen, Computerised tomogram head, Magnetic resonance imaging head, Magnetic resonance imaging neck
Clinical narrative: Transverse myelitis.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Magnetic resonance imaging spinal abnormal, Myelitis transverse
Clinical narrative: Transverse myelitis.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Dementia, Myocardial ischaemia, Syncope
Clinical narrative: DEMAND ISCHEMIA 3/6/2022 SYNCOPE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/6/2022 SYNCOPE  DEMAND ISCHEMIA 3/6/2022 ADVANCE DIRECTIVE ON FILE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/6/2022 ADVANCE DIRECTIVE ON FILE  DEMAND ISCHEMIA 3/6/2022 UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, WO BEHAVIORAL DISTURBANCE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/6/2022 UNSPECIFIED DEMENTIA, UNSPECIFIED SEVERITY, WO BEHAVIORAL DISTURBANCE  DEMAND ISCHEMIA 3/6/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/6/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE